The Engineering and Technical Operations team at Pluristem Therapeutics is responsible for ensuring the seamless development and production of human placental adherent stromal cells. This team focuses on optimizing processes, maintaining high-quality standards through rigorous quality assurance practices, and leveraging data analytics to enhance operational efficiency in the manufacturing and research phases. Their collaborative efforts support the advancement of innovative therapies for disease treatment.
View all